Synapse - Works

Results (15763)

Factors influencing outcome after pulmonary resection for colorectal cancer (CRC) metastases in the current era

Meeting Abstract

Onaitis, M. W.; Haney, J.; Petersen, R.; Saltz, L. B.; Flores, R. M.; Rizk, N.; Bains, M. S.; D'Amico, T.; Kemeny, N. E.; Rusch, V. W.; more...
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients

Meeting Abstract

Deng, G.; Smith-Jones, H. L.; Seidman, A. D.; Fornier, M.; D'Andrea, G.; Wesa, K.; Cunningham-Rundles, S.; Yeung, K. S.; Vickers, A.; Cassileth, B. R.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Phase II trial of patupilone in patients (pts) with breast cancer brain metastases (BCBM) progressing or recurring after whole brain radiation therapy (WBXRT)

Meeting Abstract

Conlin, A. K.; D'Andrea, G.; Hudis, C. A.; Robson, M. E.; Drullinsky, P.; Theodoulou, M.; Lis, E.; Kang, T. Y.; Peereboom, D. M.; Seidman, A. D.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Phase II trial of the Hsp90 inhibitor tanespimycin (Tan) + trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC)

Meeting Abstract

Modi, S.; Sugarman, S.; Stopeck, A.; Linden, H.; Ma, W.; Kersey, K.; Johnson, R. G.; Rosen, N.; Hannah, A. L.; Hudis, C. A.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Incidence and severity of sensory neuropathy (SN) with bevacizumab (B) added to dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound (nab) paclitaxel (P) in patients (pts) with early stage breast cancer (BC)

Meeting Abstract

Sierecki, M. R.; Rugo, H. S.; McArthur, H. L.; Traina, T. A.; Paulson, M.; Rourke, M.; Norton, L.; Seidman, A. D.; Hudis, C. A.; Dickler, M. N.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Dose-dense (dd) doxorubicin-cyclophosphamide (AC) X 4 and short-term changes in left ventricular ejection fraction (LVEF) alone or with bevacizumab (B) in patients (pts) with early stage breast cancer (BC)

Meeting Abstract

Morris, P. G.; Dickler, M. N.; McArthur, H. L.; Traina, T. A.; Nulsen, B.; Steingart, R. M.; Rugo, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC)

Meeting Abstract

Seidman, A. D.; Conlin, A. K.; Bach, A.; Brufsky, A. M.; Saleh, M. N.; Lake, D.; Dickler, M. N.; D'Andrea, G.; Traina, T. A.; Hudis, C. A.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Correlation of concurrent lobular neoplasia (LN) and ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ (DCIS) treated with breast-conserving therapy (BCT)

Meeting Abstract

Rudloff, U.; Brogi, E.; Brockway, J. P.; Wynveen, C. A.; Nehhozina, T.; Reiner, A.; Patil, S.; Van Zee, K. J.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Clinical and pathologic correlates in breast cancer (BC) brain metastasis (BM): Tissue microarray (TMA) studies

Meeting Abstract

Johnson, M. L.; Nehhozina, T.; Conlin, A. K.; Hsu, M.; Patil, S.; Jhaveri, K.; Hudis, C. A.; Brogi, E.; Seidman, A. D.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Standard chemotherapy (CMF or AC) versus capecitabine in early-stage breast cancer (BC) patients aged 65 and older: Results of CALGB/CTSU 49907

Meeting Abstract

Muss, H. B.; Berry, D. L.; Cirrincione, C.; Theodoulou, M.; Mauer, A.; Cohen, H.; Partridge, A. H.; Norton, L.; Hudis, C. A.; Winer, E. P.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save